Dorsey Wright & Associates Axsome Therapeutics, Inc. Transaction History

Dorsey Wright & Associates

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 31, 2020	SELL	$16.71 - $106.24 $17,662 - $112,295	-1,057 Closed	0 $0
Q2 2019 Jul 02, 2019	BUY	$13.46 - $25.75 $3,553 - $6,798	264 Added 33.29%	1,057 $27,000
Q1 2019 Apr 04, 2019	BUY	$2.63 - $16.34 $2,085 - $12,957	793 New	793 $11,000

325

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.89B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Dorsey Wright & Associates, based on Form 13F filings with the SEC.

Stay updated on Dorsey Wright & Associates with notifications on news.